Morgan Stanley analyst Devin McDermott maintains Range Resources (NYSE:RRC) with a Underweight and lowers the price target from $32 to $31.
FDA Reported Monday It Is Requiring Boxed Warning For CAR-T Cancer Therapies
https://www.fda.gov/media/175627/download?attachment
https://www.fda.gov/media/175626/download?attachment
https://www.fda.gov/media/175625/download?attachment
https://www.fda.gov/media/175624/download?attachment
https://www.fda.gov/media/175622/download?attachment
https://www.fda.gov/media/175623/download?attachment
